WINTOTCinactive

WINDTREE THERAPEUTICS INC /DE/

Healthcare·Oncology·Phase 2·Warrington, PA, United States
OncologyCardiovascular

WINDTREE THERAPEUTICS INC /DE/ (WINT): 3 pipeline candidates · ~1 mo cash runway · 1 clinical trial. Updated within the last hour.

5.6/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway0.3

1.1 months

Financial Health10.0

D/E -2.38 · 0% dilution

Pipeline Maturity6.0

Lead: Phase 1/Phase 2

Pipeline Breadth5.9

3 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for WINDTREE THERAPEUTICS INC /DE/across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$482K

Cash

$204K

Quarterly Burn

$6.4M

Runway

1.1 mo

Revenue

—

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Jul 2026
Today~7 mo out
Catalyst within runway

Pipeline (3 candidates)

DrugPhase
apkci inhibitorPreclinical
istaroximePhase 1/Phase 2
rostafuroxinPhase 2

Institutional Holdings

Source: SEC Form 13F · as of Jun 2025

Institutional holders

5

Total value held

$8K

HolderSharesValue
jane street group, llc14,599$8K
bank of america corp /de/103$53
sbi securities co., ltd.24$12
ubs group ag22$11
concourse financial group securities, inc.0$0
1 clinical trial·CEO: Mr. Jed A. Latkin

Frequently asked questions

How many drug candidates are in WINDTREE THERAPEUTICS INC /DE/'s pipeline?

WINDTREE THERAPEUTICS INC /DE/ (WINT) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is WINDTREE THERAPEUTICS INC /DE/'s lead drug candidate?

WINDTREE THERAPEUTICS INC /DE/'s most advanced tracked candidate is apkci inhibitor (Preclinical) for Solid tumors.

What is WINDTREE THERAPEUTICS INC /DE/'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, WINDTREE THERAPEUTICS INC /DE/ has approximately 1.1 months of cash runway.

What is WINDTREE THERAPEUTICS INC /DE/'s market capitalization?

WINDTREE THERAPEUTICS INC /DE/'s market capitalization is approximately $482K.

Who is the CEO of WINDTREE THERAPEUTICS INC /DE/?

Mr. Jed A. Latkin is the chief executive officer of WINDTREE THERAPEUTICS INC /DE/ (WINT).

Get the full picture on WINDTREE THERAPEUTICS INC /DE/

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar